Definium’s late-stage pipeline includes four Phase 3 trials—two each for GAD and MDD—anchored by its lead candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD.

Enphase Energy started shipping its IQ9N-3P Commercial Microinverter across the United States in late December 2025. The ...

Nurix Therapeutics (NRIX) stock: bexobrutideg’s BTK degradation shows strong efficacy in B-cell cancers, backed by $650M cash ...

Stranger Things is now moving into a new era with the original show concluded, but there's a problem with its next project.

Ramp up of Phase 1 concentrator advancing to plan; first sale of concentrate completed Shaft #3 on track for April 2026; five ...

Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company, today announced that it began production shipments of its IQ9N-3P™ Commercial Microinverter across the United States in late ...

As prominent artificial intelligence (AI) researchers eye limits to the current phase of the technology, a different approach ...

Summit Therapeutics Inc. ( SMMT) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM EST ...

SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US ...

Secretary of State Marco Rubio announces a three-phase U.S. plan for Venezuela, including oil seizures, sanctions enforcement and a political transition ...

Zentalis Pharmaceuticals (ZNTL) has come into focus after progress in its azenosertib oncology program, including completed ...